Cited by 31Reproductive tract infections researchSyphilis Diagnosis and TreatmentHIV/AIDS Research and Interventions

Systematic review and meta-analysis of doxycycline efficacy for rectal lymphogranuloma venereum in men who have sex with men.

Open access
Leeyaphan, Charussri, Ong, Jason J., Chow, Eric P.F., Kong, Fabian Y.S., Hocking, Jane S., Bissessor, Melanie, Fairley, Christopher K., Chen, Marcus·2016·Emerging infectious diseases

Abstract

Rectal lymphogranuloma venereum (LGV) has reemerged as a sexually transmitted infection among men who have sex with men (MSM), particularly those who are HIV-positive. We undertook a systematic review and meta-analysis to determine the efficacy of doxycycline (100 mg 2×/d for 21 days) for rectal LGV in MSM. Nine studies were included: 4 prospective, 4 retrospective, and 1 combined retrospective and prospective. In total, 282 MSM with rectal LGV were included in the studies. All studies reported using nucleic acid amplification tests to assess microbial cure. Most patients (>80%) had symptomatic rectal infection. The fixed-effects pooled efficacy for doxycycline was 98.5% (95% CI 96.3%-100%, I (2) = 0%; p = 0.993). Doxycycline at 100 mg twice daily for 21 days demonstrated a high microbial cure rate. These data support doxycycline at this dosage and duration as first-line therapy for rectal LGV in MSM.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3201/eid2210.160986

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The recommended 21-day course of doxycycline for LGV is based on long-standing clinical practice and is highly effective, with an estimated cure rate of >98.5%.

    “The recommended 21-day course of doxycycline is based on long-standing clinical practice and is highly effective, with an estimated cure rate of >98.5% (555,556).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [556]

    The Results (Treatment Efficacy; page not provided) estimate 98.5% microbial cure—not >98.5%—for 21-day doxycycline treatment of rectal LGV in men who have sex with men. The Discussion supports the regimen as first-line therapy, but the paper does not establish that the 21-day recommendation is based on long-standing clinical practice or that this cure estimate applies to all LGV. (LLM, conf=0.89)

    Experimental — accuracy not yet measured
  • Genital HSV and LGV proctitis are more prevalent among persons with HIV infection.

    “Genital HSV and LGV proctitis are more prevalent among persons with HIV infection (545,556,1382).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [556]

    The Abstract (page unavailable) says rectal LGV infections are overrepresented among HIV-positive men who have sex with men, supporting the LGV part of the claim in that population. The paper does not address whether genital HSV is more prevalent among people with HIV, and its LGV evidence does not establish the claim for all persons with HIV. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 39 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Leeyaphan, C., Ong, J. J., Chow, E. P. F., Kong, F. Y. S., Hocking, J. S., Bissessor, M., Fairley, C. K., & Chen, M.
Affiliations
The University of Melbourne (AU)
Corresponding author
Chen, Marcus
Venue
Emerging infectious diseases
Published
2016-10
Volume
22
Issue
10
Pages
1778-1784
ISSN
  • 1080-6040 (ISSN-L)
  • 1080-6059
OpenAlex
W2509082357
Cited by
31
References
39
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 7 · 2020: 2 · 2019: 2 · 2018: 5 · 2017: 6
FWCI
0.48
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Emerging infectious diseases (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Mahidol University
  • Medical Research Council
  • National Health and Medical Research Council (1091226, 1104781)
  • Faculty of Medicine Siriraj Hospital, Mahidol University
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
  • Health Sciences › Medicine › Physiology › Syphilis Diagnosis and Treatment
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords
lymphogranuloma venereum, rectal infection, doxycycline, men who have sex with men, sexually transmitted infections, HIV coinfection, treatment efficacy, Chlamydia trachomatis, first-line therapy
MeSH terms
Anti-Bacterial Agents, Chlamydia trachomatis, Doxycycline, Humans, Lymphogranuloma Venereum, Male, Rectal Diseases, Treatment Outcome, Homosexuality, Male

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review